Menu
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 11
Original Research
Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 1,204 | Dovepress* | 1,105+ | 27 | 1,132 | |
| PubMed Central* | 99 | 40 | 139 | ||
| Totals | 1,204 | 67 | 1,271 | ||
| *Since 4 March 2024 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 10 | 0 | 0 | 0 | 5 | 5 |
View citations on PubMed Central and Google Scholar